TCG Crossover Management »

Vor Biopharma shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Vor Biopharma (VOR) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Vor Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Vor Biopharma held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vor Biopharma by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $97M 5.7M 17.01

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Tango Therapeutics Comm (TNGX)
Cogent Biosciences Comm (COGT)
Centessa Pharmaceuticals Adrs (CNTA)
Dianthus Therapeutics Comm (DNTH)
Tyra Biosciences Comm (TYRA)
Immunovant Comm (IMVT)
Biocryst Pharmaceuticals Comm (BCRX)
Mirum Pharmaceuticals Comm (MIRM)
Vor Biopharma Comm (VOR)
Spyre Therapeutics Comm (SYRE)
Amylyx Pharmaceuticals Comm (AMLX)
Disc Medicine Comm (IRON)
Dyne Therapeutics Comm (DYN)

View all positions for TCG Crossover Management

Top funds holding Vor Biopharma

TCG Crossover Management
RA Capital Management
Fcpm Iii Services B.v.
VR Adviser
Frazier Life Sciences Management
FMR
Dr. Jeffrey R. Jay, M.D.
Paradigm Biocapital Advisors
Vanguard Capital Management
Susquehanna International
Caligan Partners
BlackRock
Vanguard Group
Logos Global Management
Boothbay Fund Management

View all funds holding Vor Biopharma